• In recent days, FIGS has seen heightened investor attention after insider stock sales by its CEO and CFO under a pre-arranged 10b5-1 plan, alongside mixed institutional trading activity and cautious technical commentary around key support levels.
• This combination of insider selling and profit-taking, following an earlier earnings-fueled rally and takeover chatter, has sharpened focus on how short-term sentiment may diverge from the company’s longer-term fundamentals.
• Now we’ll examine how these insider sales and associated investor concerns might influence FIGS’ existing investment narrative around growth and margins.

The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

FIGS Investment Narrative Recap

To own FIGS, you generally need to believe its direct to consumer model in healthcare apparel can keep supporting healthy margins while managing tariffs, competition and expansion risk. The recent 10b5 1 insider sales and technical weakness mainly affect sentiment rather than the core business story, although they may sharpen attention on how FIGS balances margin protection with slower promotional activity in the near term.

Against that backdrop, the latest Q4 2025 earnings are especially relevant. FIGS reported full year 2025 revenue of US$631.1 million and net income of US$34.25 million, with higher profit margins than the prior year. This profitability progress is central to the current investment narrative, so investors are now weighing those results against concerns about insider selling, tariff exposure and the risk that slower promotional activity could cool customer growth.

Yet, while recent results were encouraging, investors should still watch how rising tariffs and softer promotions could affect FIGS’ margins and demand...

FIGS’ narrative projects $782.4 million revenue and $67.7 million earnings by 2029.

Uncover how FIGS' forecasts yield a $16.31 fair value, a 21% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were assuming FIGS could reach about US$671.2 million of revenue and US$39.1 million of earnings, yet the recent insider selling and volatility might prompt you to question whether those expectations as well as concerns about competition and innovation still hold up, or if the story is shifting in ways that call for considering very different viewpoints.

Explore 4 other fair value estimates on FIGS - why the stock might be worth less than half the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your FIGS research is our analysis highlighting 2 key rewards that could impact your investment decision.
• Our free FIGS research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate FIGS' overall financial health at a glance.

Searching For A Fresh Perspective?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Capitalize on the AI infrastructure supercycle with our selection of the 36 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource.
• Find 61 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.